The most common adverse events were hypercalcemia, nausea, and diarrhea.
Very common (10% or more): Hypercalcemia (16.
3%)
Hypercalcemia was usually asymptomatic or manifested as constipation, anorexia, nausea, and vomiting, and in 0.
1% of patients caused confusion, delirium, stupor, or coma.
Very common (10% or more): Nausea (14%), diarrhea (13.
2%)Common (1% to 10%): VomitingUncommon (0.
1% to 1%): Constipation
Common (1% to 10%): Pruritus
Uncommon (0.
1% to 1%): Soft tissue calcification Postmarketing reports: Edema, weakness
Postmarketing reports: Dizziness
Abdominal or stomach pain
confusion
constipation
depression
dry mouth
full or partial loss of consciousness
headache
incoherent speech
increased urination
loss of appetite
metallic taste
muscle weakness
nausea or vomiting
thirst
unusual tiredness
weight loss
Swelling
Diarrhea
Itching
Dizziness
weakness